DRIO
DarioHealth Corp
6.60$
+0.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 66.7% | 84.4% | 75.8% | 86.9% | 94.5% | 93.3% | 96.4% | 45.3% | 55.0% | 49.1% | 34.1% | 31.6% | |
| 47.2% | 52.6% | 28.2% | 53.4% | 78.1% | 83.8% | 80.7% | 35.7% | 41.4% | 38.2% | 23.4% | 23.8% | |
| 49.9% | 54.2% | 34.0% | 57.2% | 78.1% | 83.8% | 80.7% | 35.7% | 41.4% | 38.2% | 23.9% | 23.8% | |
| 1.1% | 0.4% | 7.5% | 6.3% | 1.7% | 2.9% | 4.8% | 1.8% | 5.4% | 3.8% | 4.5% | 2.4% | |
| 7.6% | 11.8% | 22.9% | 17.0% | 9.8% | 5.8% | 6.5% | 6.2% | 6.7% | 5.3% | 4.0% | 3.9% | |
| 31.7% | 14.8% | 23.3% | 12.5% | 5.2% | 5.8% | 1.6% | 0.7% | 0.7% | – | – | – | |
| – | – | – | – | – | – | 0.0% | 41.3% | 34.9% | 43.2% | 48.3% | 52.2% | |
| – | – | – | – | – | – | – | 12.4% | 8.3% | 5.6% | 15.8% | 14.5% | |
| 182.4% | 84.7% | 268.9% | 43.4% | 36.7% | 23.1% | 20.5% | 15.1% | 32.9% | 39.7% | 39.4% | 38.3% | |
| 52.5% | 33.3% | 75.5% | 43.3% | 36.7% | 21.2% | 19.9% | 14.3% | 16.2% | 13.0% | 14.0% | 8.5% | |
| – | – | – | – | – | 1.3% | 0.9% | 0.3% | 7.6% | 4.2% | 5.0% | 0.4% | |
| 23.0% | 19.3% | 46.8% | 26.6% | 18.3% | 6.7% | 7.0% | 5.1% | 1.9% | 1.2% | 2.6% | 2.7% | |
| – | 46.4% | – | – | – | – | – | – | 15.2% | 25.5% | 19.7% | 27.9% | |
| -82.4% | 15.3% | -168.9% | 56.6% | 63.3% | 76.9% | 79.5% | 84.9% | 67.1% | 60.3% | 60.6% | 61.7% | |
| -1,170.3% | -853.9% | -1,419.4% | -1,020.0% | -633.5% | -448.3% | -404.6% | -220.3% | -239.8% | -362.4% | -328.3% | -410.7% | |
| 0.8% | 1.9% | 6.7% | 6.9% | 8.3% | 9.2% | 16.8% | 16.5% | 19.8% | 29.4% | 34.0% | 45.1% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.